Samsung BioLogics says mass producing Eli Lilly’s COVID-19 treatments – Reuters India

By Reuters Staff
FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake
SEOUL (Reuters) – Samsung BioLogics said … [read more]

Leave a Comment